Search results
Results from the WOW.Com Content Network
Feb 2024-. Board member of. Emergent BioSolutions. Children. 3. Joseph C. Papa (born October 1, 1955) is an American businessman and the chairman and chief executive officer (CEO) of Bausch & Lomb, a company formed from the initial public offering (IPO) of the eye health business of Bausch Health Companies Inc. [1]
Bausch & Lomb (since 2010 stylized as Bausch + Lomb[ 2]) is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, [ 3] lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. [ 4][ 5] The company was founded in Rochester ...
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health ...
The Bausch Health Thesis: The remaining company, after spinning off the B&L unit, will face “risk of multiple compression” as it is highly levered to Xifaxan, Gerberry said in the downgrade note.
On Thursday, Bausch Health Companies (NYSE:BHC) reported a second-quarter 2024 GAAP EPS of $0.03 compared to the consensus of $0.28. The company reported revenues of $2.403 billion, up 11% year ...
Bausch & Lomb Corp filed S-1 for its initial public offering, nearly 1.5 years after its parent company, Bausch Health Companies Inc (NYSE: BHC) said it would spin off the eye-care company. The ...
The firm renamed itself Bushnell Performance Optics. Three years later, Bushnell retired as vice-president of Bausch & Lomb. [2] In 1999, Bausch & Lomb sold Bushnell Performance Optics to the private equity firm Wind Point Partners through a recapitalization of Bushnell's then parent company, Worldwide Sports & Recreation. [3] [4] [5]
Bausch said in March it would sell its entire stake in Egypt's Amoun Pharmaceutical Co SAE and last year announced plans to spin off Bausch + Lomb. UPDATE 2-Bausch Health plans IPO for medical ...